about
Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol?Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 AdultsComparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins.Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility.Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver diseaseOveractivation of intestinal Sterol Response Element Binding Protein 2 promotes diet-induced non-alcoholic steatohepatitis.A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.Review. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease.Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes.Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies.Intestinal resection-associated metabolic syndrome.Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts.Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic miceEffects of Leaves Extract on High Glucose-Induced Metabolic Changes in HepG2 CellsCoadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study
P2860
Q33616737-07A30261-C21D-47FA-9644-1C3EE7F210BFQ33875821-47D50DCB-CA0E-48A7-9C8A-F8AF8675A988Q35964678-F6170E88-0BC7-4136-ACE9-70667F29DD0FQ37587055-1F90769E-61E2-4C63-B401-E86B7CD358F7Q37714347-9C9ADC24-AD19-49A0-94D0-5A636BD98534Q38642491-658F3C01-240C-44C1-B768-3E2D788FE6FDQ38718299-F29C98CB-95CC-4934-86B0-B4CE6AE2134EQ39148023-D44B53B7-093F-480D-AFD7-659FFAFF1B9CQ46268603-BD8C328E-ED70-4F6F-BEF3-CB6B7ADFF3BBQ47632942-E7D1D099-B16D-4116-AD73-6AA2D7831B95Q51244167-37F2810D-E6AE-494F-9C88-09CF50EE9DB8Q53695403-1BE4C43C-A960-4514-8AC1-51D65201DA45Q55715558-AFEB8029-F0D4-445B-8F5C-755CEB708D62Q57069721-467EE9A9-3A10-4AAA-834D-9E89BB9A8FE4Q57245574-1B408C2C-DCE8-4EC4-9A81-086FA8848835Q58792130-64C75F56-F64C-4EAC-99CA-36F6178E2637
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Fatty liver disease in diabetes mellitus
@ast
Fatty liver disease in diabetes mellitus
@en
Fatty liver disease in diabetes mellitus
@nl
type
label
Fatty liver disease in diabetes mellitus
@ast
Fatty liver disease in diabetes mellitus
@en
Fatty liver disease in diabetes mellitus
@nl
prefLabel
Fatty liver disease in diabetes mellitus
@ast
Fatty liver disease in diabetes mellitus
@en
Fatty liver disease in diabetes mellitus
@nl
P2860
P1476
Fatty liver disease in diabetes mellitus
@en
P2093
P2860
P356
10.3978/J.ISSN.2304-3881.2015.01.03
P407
P577
2015-04-01T00:00:00Z